Inotiv, inc. expands protein/peptide bioanalytical capabilities with acquisition of protypia, inc.

West lafayette, ind., july 07, 2022 (globe newswire) -- inotiv, inc. (nasdaq: notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that the company has completed the purchase of nashville, tennessee based protypia, inc. (“protypia”). protypia is an emerging protein/peptide bioanalytical company offering high-quality, targeted tissue-based protein and peptide mass spectrometry.
NOTV Ratings Summary
NOTV Quant Ranking